Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ImaRx Therapeutics (Urokinase Business)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of bio pharmaceutical products. The company manufactures thrombolytic which is used in treatment of acute massive pulmonary embolism.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 6860 Lexington Avenue
  • Suite 120
  • Los Angeles, CA 90038
  • United States

ImaRx Therapeutics (Urokinase Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ImaRx Therapeutics (Urokinase Business)‘s full profile, request access.

Request full access to PitchBook

ImaRx Therapeutics (Urokinase Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore ImaRx Therapeutics (Urokinase Business)‘s full profile, request access.

Request full access to PitchBook